Literature DB >> 23589636

Autosomal dominant vasovagal syncope: clinical features and linkage to chromosome 15q26.

Karl Martin Klein1, Catherine J Bromhead, Katherine R Smith, Christopher J O'Callaghan, Susan J Corcoran, Sarah E Heron, Xenia Iona, Bree L Hodgson, Jacinta M McMahon, Kate M Lawrence, Ingrid E Scheffer, Leanne M Dibbens, Melanie Bahlo, Samuel F Berkovic.   

Abstract

OBJECTIVE: To establish the occurrence of an autosomal dominant form of vasovagal syncope (VVS) by detailed phenotyping of multiplex families and identification of the causative locus.
METHODS: Patients with VVS and a family history of syncope were recruited. A standardized questionnaire was administered to all available family members and medical records were reviewed. Of 44 families recruited, 6 were suggestive of autosomal dominant inheritance. Genome-wide linkage was performed in family A using single nucleotide polymorphism genotyping microarrays. Targeted analysis of chromosome 15q26 with microsatellite markers was implemented in 4 families; 1 family was too small for analysis.
RESULTS: Family A contained 30 affected individuals over 3 generations with a median onset of 8 to 9 years. The other families comprised 4 to 14 affected individuals. Affected individuals reported typical triggers of VVS (sight of blood, injury, medical procedures, prolonged standing, pain, frightening thoughts). The triggers varied considerably within the families. Significant linkage to chromosome 15q26 (logarithm of odds score 3.28) was found in family A. Linkage to this region was excluded in 2 medium-sized families but not in 2 smaller families. Sequence analysis of the candidate genes SLCO3A1, ST8SIA2, and NR2F2 within the linkage interval did not reveal any mutations.
CONCLUSIONS: Familial VVS, inherited in an autosomal dominant manner, may not be rare and has similar features to sporadic VVS. The chromosome 15q26 locus in family A increases the susceptibility to VVS but does not predispose to a particular vasovagal trigger. Linkage analysis in the remaining families established likely genetic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23589636     DOI: 10.1212/WNL.0b013e31828cfad0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Dominant Transmission Observed in Adolescents and Families With Orthostatic Intolerance.

Authors:  Jennifer E Posey; Rebecca Martinez; Jeremy E Lankford; James R Lupski; Mohammed T Numan; Ian J Butler
Journal:  Pediatr Neurol       Date:  2016-09-24       Impact factor: 3.372

Review 2.  Current approach to the treatment of vasovagal syncope in adults.

Authors:  Tarek Hatoum; Satish Raj; Robert Stanley Sheldon
Journal:  Intern Emerg Med       Date:  2022-09-18       Impact factor: 5.472

3.  Biogenic amine metabolism in juvenile neurocardiogenic syncope with dysautonomia.

Authors:  Ian J Butler; Jeremy E Lankford; Syed Shahrukh Hashmi; Mohammed T Numan
Journal:  Ann Clin Transl Neurol       Date:  2014-03-26       Impact factor: 4.511

Review 4.  The Search for the Genes of Vasovagal Syncope.

Authors:  Robert S Sheldon; Roopinder K Sandhu
Journal:  Front Cardiovasc Med       Date:  2019-11-28

5.  Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.

Authors:  Leweihua Lin; Tuanyu Fang; Lu Lin; Qianying Ou; Huachuan Zhang; Kaining Chen; Huibiao Quan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-01       Impact factor: 5.555

6.  Predictor of Syncopal Recurrence in Children With Vasovagal Syncope Treated With Metoprolol.

Authors:  Chunyan Tao; Bowen Xu; Ying Liao; Xueying Li; Hongfang Jin; Junbao Du
Journal:  Front Pediatr       Date:  2022-04-08       Impact factor: 3.569

7.  Genetic Analysis of Cardiac Syncope-Related Genes in Korean Patients with Recurrent Neurally Mediated Syncope.

Authors:  Sung Ho Lee; Jong Eun Park; Chang-Seok Ki; Seung-Jung Park; Young Keun On; Kyoung-Min Park; June Soo Kim
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.